WHY GOOD PAIN MANAGEMENT IS GOOD DRUG ABUSE PREVENTION

Similar documents
OPIOID RISK ASSESSMENT IN CANCER PATIENTS. Bob Twillman, Ph.D., FAPM Executive Director Academy of Integrative Pain Management

The Oregon Opioid Initiative. State Pain & Opioid Conference Prescription Drug Monitoring May 2018 Lisa Millet, Public Health Division

Opioid Review and MAT Clinic CDC Guidelines

Appropriate Opioid Prescribing for Acute Pain after Surgery

Reversing America s Opioid Epidemic. August 2017

OPIOID PRESCRIBING RULES. May 17, 2017 Webinar

The Future of Prevention: Addressing the Prescription Drug Abuse and the Opioid/Heroin Epidemic in our Country

The 86 th Texas Legislature s Policy Response to Opioids Prepared by the Texas Orthopaedic Association

Michael M. Miller, MD, FASAM, FAPA

Appropriate Opioid Prescribing for Acute Pain after Surgery

October 15, Division of Dockets Management (HFA 305) Food and Drug Administration 5630 Fishers Lane, Room 1061 Rockville, MD 20852

Changing Prescribing Practices In Dentistry

STATEMENT. of the. American Medical Association. for the Record. House Committee on Energy and Commerce

PRESCRIPTION DRUG ABUSE: THE NATIONAL PERSPECTIVE

Aligning Market Objectives and Policy for National Public Health

Potential Solutions to Epidemic Substance Abuse in US and Europe

Effect of Abuse-Deterrent Formulations and IR Opioids on Abuse, Overdose and Death from Rx Opioids

Pennsylvania Prescription Drug Monitoring Program Trends,

Prescription Drug Abuse:

July 6, Scott Gottlieb, MD Commissioner U.S. Food and Drug Administration New Hampshire Avenue Silver Spring, MD 20993

New Guidelines for Prescribing Opioids for Chronic Pain

The Challenge of Treating Pain

Prescription Drug Abuse National Perspective

Integrated Care Approach to Chronic Pain. David Charles, MD

Rule Governing the Prescribing of Opioids for Pain

CDC Guideline for Prescribing Opioids for Chronic Pain. Centers for Disease Control and Prevention National Center for Injury Prevention and Control

Implementation: Public Hearing: Request for Comments (FDA-2017-N-6502)

11/11/2015. MVAs Suicide Firearms Homicide. Where Can I Find A Copy of the PDMP Law? Why Was the Law Established? Why Was the Law Established?

Morrison County Community-Based Care Coordination. Our Core Values Reverence Integrity Compassion Excellence

Academic Medical School: Implementing Curriculum in Chronic Pain and Opioid Misuse. Jill M Williams, MD

American Academy of Pain Medicine American Pain Society American Society of Anesthesiologists

Improving Opioid Stewardship Amidst an Opioid Crisis

Trends and Challenges: The Kentucky Opioid Crisis. Jason Smith, MD PhD University of Louisville

5 A s Opioid therapy monitoring tool

Pain Care & Prescription Drug Abuse: Current Topics, Legislation & Policy. Disclosure. Preview

Strategies for Federal Agencies

The Role of Dentists in Preventing Opioid Abuse Tufts Health Care Institute Program on Opioid Risk Management 12 th Summit Meeting March 11-12, 2010

California. Prescribing and Dispensing Profile. Research current through November 2015.

EXECUTIVE ORDER TAKING FURTHER ACTIONS TO ADDRESS THE OPIOID OVERDOSE CRISIS

Public Health Federal Funding Request to Address the Opioid Epidemic

Opioid Prescribing Tips & Tricks CANDY STOCKTON, MD MAY 2018

Preventing Prescription Opioid Misuse Among Student Athletes

Battling Opioid Addiction: Public Policy and Healthcare Strategies for an Epidemic

High-Decile Prescribers: All Gain, No Pain?

Opioid Use and Other Trends

Our Core Thoughts on Dealing with the Opioid Addiction Crisis. Meghan McNelly, PharmD, MHA, FACHE Suzette Song, MD Joseph Alhadeff, MD

Key Findings and Recommendations from the

Removing the Stigma from Substance Use Disorder. Joan Duwve, MD, MPH Associate Dean for Practice Richard M. Fairbanks School of Public Health

Rhode Island. Prescribing and Dispensing Profile. Research current through November 2015.

EMERGENCY DEPARTMENT MODEL PRACTICES DEALING WITH THE PRESCRIPTION OPIOID EPIDEMIC

I. Chronic Pain Information Page 2-3. II. The Role of the Primary Care Physician in Chronic Pain Management Page 3-4

Working with People Who Use Drugs in HIV Care Settings. August 29, 2017 Workshop C 2:00 3:30 p.m.

Opioid Task Force Kick-Off Meeting. February 29, 2016

The Opioid Crisis: Effectiveness of State Responses

Opioid Management of Chronic (Non- Cancer) Pain

The Opioid Epidemic: What is the Role of Acute Pain Prescribing?

Mandatory PDMP Use PDMP Use STATE Prescriber Dispenser Conditions, if applicable

GENERAL ASSEMBLY OF NORTH CAROLINA SESSION HOUSE BILL DRH20012-MGfa-35H* (01/26)

Virginia. Prescribing and Dispensing Profile. Research current through November 2015.

Michigan Opioid Legislation Hospital Compliance Checklist

Minnesota. Prescribing and Dispensing Profile. Research current through November 2015.

Do you CARA? A Deep Dive Into the Comprehensive Addiction and Recovery Act Joel White, President

House Committee on Energy and Commerce House Committee on Energy and Commerce. Washington, DC Washington, DC 20515

The Difficult Patient: Risk Mitigation Strategies

Update: How the CDC Guidelines Are Impacting Patient Care

ScO.S. Academic Detailing for Safer Prescribing

Strategies to Manage The Opioid Crisis

Legal Issues in Opioid Prescribing

Mandatory PDMP Use PDMP Use STATE Prescriber Dispenser Conditions, if applicable

Policy and Political Dynamics of the Opioid Addiction Crisis in the United States

Establishment of an Opioid Stewardship Program. Cindy Williams, BS Pharm, FASHP VP/Chief Pharmacy Officer Riverside Health System

The Prescription Opioid and Heroin Crisis

SC MAT ACCESS. Medication Assisted Treatment Academic Community Capacity Expansion for Sustainable Success Kathleen Brady, MD, PhD, VPR, MUSC

The Opioid Crisis Made in America Fade in America?

A LOOK AT ABUSE-DETERRENT OPIOIDS

Hydrocodone Combination Analgesic Products Clinical Impact of a Schedule Change

Best Practices and Foundation Forum. Fred Wells Brason II

Evidence-Based Postoperative Opioid Prescribing Guidelines

University of Pittsburgh

QUARTERLY PROVIDER MEETING MARCH 9, 2017 SUZANNE BORYS, ED.D.

Implementing the 2017 President s Challenge: Primary, Secondary & Tertiary Prevention of Addiction & Substance Misuse

Resist the Opioid Pendulum: Understanding Opioids and Pain, and how they relate to Addiction

Aniston's 'Cake' shines a light on Rx drug abuse epidemic

Interventions in Prescription Opioid Abuse Do (or can) Prescription Monitoring Programs Make a Difference?

AHLA. X. Federal Enforcement of Fraud and Abuse Involving Opioid Abuse and Diversion

Today s Presenters. Pills, Providers, and Problems: How to Investigate Drug Diversion in Long-Term Care

ACCG Mental Health Summit

Naloxone and Combating the Opioid Epidemic

Wednesday, June 21, Dear Chairmen and Ranking Members:

September 1, The Honorable Tom Price, MD Secretary Department of Health and Human Services 200 Independence Avenue SW Washington, DC 20201

Addressing the Opioid Epidemic: Prescribing Opioids for Non-Cancer Pain

Breakthrough Cancer Pain (BTCP) 25 Years of Study: Key Insights

On December 27, 2017, the Lieutenant Governor signed into law several new requirements

Evaluation of the N.C. Prescription

OPIOIDS: THE GOOD, THE BAD, AND EVERYTHING IN-BETWEEN

Oregon ACEP Opioid Prescribing Guidelines. Why are we talking about this?

North Dakota Board of Pharmacy

ADDRESSING THE OPIOID EPIDEMIC. Joint principles of the following organizations representing front-line physicians

Louisiana. Prescribing and Dispensing Profile. Research current through November 2015.

THE PROS & CONS OF THE CDC GUIDELINES FOR SAFE OPIOID PRESCRIBING

Transcription:

WHY GOOD PAIN MANAGEMENT IS GOOD DRUG ABUSE PREVENTION Bob Twillman, Ph.D., FAPM Executive Director Academy of Integrative Pain Management Walking the Tightrope of Pain Management Adverse Events Misuse Death Addiction Diversion Abuse Two Major Public Health Problems Prescription opioid abuse: 12.5 million non-medical users per year $70-120 billion cost per year 16,000-19,000 overdose deaths per year (maybe) Chronic pain: >100 million with chronic pain, ~25-39 million with daily chronic pain, ~10 million disabled $560-635 billion cost per year Suicide risk doubled 42,800 suicide deaths in 2014 ~28,000 were people with chronic pain 1

More Commonalities than Differences Prescription drug abuse and chronic pain are more alike than different: Both are highly prevalent Both are very costly, in economic and human terms Both highly stigmatized--patients are blamed Both are poorly understood by the medical profession Both are under-resourced vis-à-vis treatment Both are complex problems, with many moving parts Both best addressed with a biopsychosocial approach Most importantly: Both involve tremendous suffering Not A Zero-Sum Game Often, it feels like any attempt to prevent prescription opioid abuse must be accomplished by reining in prescribing, potentially increasing pain and decreasing function Similarly, it often seems as though any effort to improve pain management must involve increased prescribing, which could, in turn, lead to more adverse outcomes I believe this misstates the case, and that it is possible to address both problems without adversely affecting either by providing balanced pain management A Thought For every complex problem, there is a solution that is neat, simple, and wrong H.L. Mencken I believe that implementing overly simplistic policy solutions for these two very complex problems leads to the zero-sum game that we so often perceive Perhaps the solutions we should be seeking are as complex as the problems we are trying to solve 2

Overdose Deaths Involving Prescription Opioids Statistics are somewhat squishy due to Coding, and counting, multiple causes of death for one decedent Difficulty distinguishing between parent drug and metabolites Difficulty distinguishing between licit and illicit forms of the same drug, especially fentanyl Overdose Deaths Involving Prescription Opioids Overdose Deaths Involving Opioids 3

Overdose Deaths Involving Prescription Opioids Most are poly-substance overdoses: Previous CDC research suggests that about 75-80% of decedents used multiple drugs, not including alcohol Among drug overdose decedents in Florida in the first half of 2013, the state medical examiners network reported that 93.5% had multiple drugs on board Most decedents don t have active prescriptions: Two studies (one from CDC) show that as many as 55-60% did not have an active prescription for the drugs involved Recent research in Massachusetts revealed that only 8% of decedents had active prescriptions We need much better understanding of what these numbers mean, so we can craft better solutions Filtering the Noise to Find the Signal One key task in statistics is reducing or eliminating the noise to detect the true signal Drug overdose data have always been pretty noisy, but the static is increasing Detecting the true signal is very challenging What s happening to prescription drug abuse rates? Increasing? Stable? Decreasing? 4

How Do We Explain This? 20000 18000 16000 14000 12000 10000 8000 6000 Rx Opioid OD Deaths 7456 10928 8517 13723 9857 14408 15597 14800 16917 16651 16007 18893 16235 2002 2004 2006 2008 2010 2012 2014 Rx Opioid OD Deaths 6.0 5.0 4.0 3.0 2.0 1.0 0.0 NSDUH data: Non-medical use, opioid use disorder rates (%) in people > 12 years old 4.7 4.9 4.7 4.9 5.1 5.0 4.8 4.9 4.8 4.3 4.8 4.2 3.9 0.6 0.6 0.6 0.6 0.7 0.7 0.7 0.8 0.7 0.7 0.6 0.6 0.7 Past Yr NMU 2002 2004 2006 2008 2010 2012 2014 Past Year OUD Asking the Right Questions To get the right answers, we have to ask the right questions The Right Question about Opioids for Chronic Pain The wrong question is, Should we use opioids to treat chronic pain? The right question is, In which patients should we use opioids, at what doses, for how long, with which adjunctive treatments, and with what precautions? 5

Pathways to Prevention Findings In September 2014, NIH sponsored a two-day Pathways to Prevention workshop on The Role of Opioids in the Treatment of Chronic Pain Extensive evidence review was carried out prior to the meeting After the meeting, an unbiased panel developed a report regarding the risks and benefits of using opioids to treat chronic pain The key conclusion: What was particularly striking to the panel was the realization that there is insufficient evidence for every clinical decision that a provider needs to make regarding the use of opioids for chronic pain, leaving the provider to rely on his or her own clinical experience. Question: If that s the case, then how do we find our way out of the mess we re in? Revisiting the Role of Opioids for Chronic Pain Careful, judicious use of opioids with both pain relief and patient safety in mind is appropriate in pain management. Opioids are necessary, but we need other tools as well: Within the context of an integrative model of care, the Academy recognizes the effectiveness of opioids as part of a comprehensive treatment plan for some people who experience chronic pain. When prescribed judiciously by clinicians who are well educated about prescribing these medications, and taken as directed by patients who are well informed about these medications, opioids may be useful in reducing pain and restoring function. Appropriate Treatment for Chronic Pain Appropriate treatment for chronic pain is multimodal, including interventions like exercise, nutrition, integrative medicine treatments, medications not just opioids, because there may be others that work better This kind of treatment focuses primarily on improving function, rather than focusing totally on pain intensity Use of multiple types of treatment should reduce reliance on opioid analgesics as a primary means of treating pain Multiple barriers exist to providing this type of care for chronic pain 6

Appropriate Treatment for Chronic Pain (cont.) If all you have is a hammer, every problem looks like a nail. Abraham Maslow The biopsychosocial model recognizes the need to use multiple tools to fix the broken system that results in chronic pain Unfortunately, the system that provides those tools also is broken. We need more tools, and better access to the tools we have. This requires: More basic medical education content for traditional students Extensive continuing education for licensed providers Available providers of non-medication treatments Access to referral networks for those providers Adequate reimbursement for those providers Guidelines for Treating Chronic Pain Increasingly, we are seeing governmental agencies issue guidelines for the treatment of chronic pain The focus of these guidelines tends to be heavily on appropriate use of opioids in this setting ALL of these guidelines are based, almost entirely, on expert opinion Guideline issued on March 15, 2016 by the CDC is a prime example Good Evidence is Lacking Remember the Pathways to Prevention expert panel statement: What was particularly striking to the panel was the realization that there is insufficient evidence for every clinical decision that a provider needs to make regarding the use of opioids for chronic pain, leaving the provider to rely on his or her own clinical experience. 7

Good Evidence is Lacking Lack of evidence rarely inhibits policymakers who see an opportunity Legislating the CDC Guideline: Dose Limits Rhode Island H 8224: Limits opioids for acute pain to no more than 30 MME/day for a maximum of 20 doses Maine: 300 MME/day maximum dose initially; as of 7/1/17, 100 MME/day maximum dose; no more than a 30- day supply in a 30-day period for chronic pain; no more than a 7-day supply in a 7-day period for acute pain Exceptions: Active and aftercare cancer treatment, palliative care, end-of-life and hospice care, MAT for SUD, or other circumstances by rule Similar legislation introduced in Pennsylvania and Michigan Legislating the CDC Guideline s Acute Pain Recommendation: 2016-2017 DC 15-Day Limit 10-Day Limit 7-Day Limit 5-Day Limit 3-Day Limit 8

ACUTE PAIN Excess Supplies of Opioids in Acute Pain Prescriptions for acute pain have also been noted by some as the source of excess opioid doses One case example will illustrate this point; many people have similar stories Acute Pain Management Case 53 y/o female has arthroscopic knee surgery for partial medial meniscectomy. Patient has a history of adverse reaction to hydrocodone/ APAP (full body rash). The surgeon prescribed oxycodone/apap, along with an NSAID and an ice machine. 9

Acute Pain Management Case Here is how much oxycodone/apap was actually used by the patient: Acute Pain Management Case Here is how much oxycodone/apap was left over: Why Does This Happen??!? Surgeons are doing what they learned to do in their training They are motivated to ensure that their patients have adequate pain relief They have a hard time accommodating patients who run out of medication, so they prescribe as if every patient uses as much as the patient at the 99 th percentile Note that hydrocodone rescheduling may be exacerbating this Partial fill legislation may alleviate this They may not know the 50 th percentile, or median, dose 10

The Right Question about Prescription Opioid Supplies How can we reduce the supply of prescription opioids? is the wrong question The right question is, How can we reduce the EXCESS supply of prescription opioids? How do we define excess? Data on Prescribing for Surgical Pain Hill et al., 2017, Annals of Surgery Studied opioids prescribed for five common outpatient surgeries Surveyed patients to determine how much of prescribed medication was used Calculated the number of pills needed to supply the needs of 80% of patients Calculated potential pill savings if this number was prescribed Data on Prescribing for Surgical Pain Surgery Median Rx d Range Rx d Percent Taken 80th %ile Partial Mastectomy Partial Mastectomy + Sentinel LN Biopsy Laparoscopic Cholecystectomy Lap Inguinal Hernia Repair Open Inguinal Hernia Repair 20 0-50 15 5 20 0-60 25 10 30 0-100 33 15 30 15-70 15 15 30 15-120 31 15 N = 642; if 80 th percentile amount was prescribed, would save 9,787 pills 11

Data on Prescribing for Surgical Pain In a follow-up study, authors educated surgeons about their findings, and encouraged use of NSAID/ acetaminophen Mean number of pills prescribed decreased: PM: from 19.8 to 5.1 PM+SLNB: from 23.7 to 9.6 Lap Chole: from 35.2 to 19.4 Lap Ing Hernia: from 33.8 to 19.3 Open Ing Hernia: from 33.2 to 18.3 Overall, 53% decrease in pills prescribed Only 1 of 246 patients in study needed a refill Other Possible Solutions Conduct a PDMP check prior to discharge, so that patients with medications already at home are taught how to use them appropriately, rather than dispensing a new excess supply Allow partial fills of prescriptions, with remainder still available if needed CARA bill allows this at the federal level DEA is writing regulations to enact this law Some state laws will need to be changed to allow this Patient Safety Best Practices Pursue a balanced, multi-disciplinary approach to providing pain care Individualize treatment plans for each person with pain there is no cookbook, and one size doesn t even fit most Decrease opioid prescribing by incorporating multimodal analgesia Emphasize proper use, storage, and disposal; educate people with pain, family members, other loved ones and caregivers 12

A Final Word Medical professionals, especially those specializing in pain management, want to be part of the solution that enables us to provide pain care that is both safe and effective In part, we need to better use some tools we already have In part, we need some additional tools to effectively treat both acute and chronic pain in ways that don t exacerbate prescription drug abuse and other adverse outcomes We need to assert our appropriate role in developing solutions that promote balanced pain management, on behalf of ourselves and the people with pain for whom we care Thank you for your attention 13